NCT05961605 is a clinical trial in Psoriasis Patients, sponsored by Gang Wang, MD.

Who is sponsoring NCT05961605?

NCT05961605 is sponsored by Gang Wang, MD.

What condition does NCT05961605 study?

NCT05961605 studies Psoriasis Patients, COVID-19.

Is NCT05961605 still recruiting?

NCT05961605 is currently status unknown. Last updated 1 August 2023.

Last reviewed 2023-08-01 · How we verify

NCT05961605

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

COVID-19 Associated With Psoriasis

Status unknown Last updated 1 August 2023

What this trial tests

trial in Psoriasis Patients in 2,500 participants. Status unknown.

Timeline

15 March 2023

Primary endpoint
30 May 2023

30 July 2023

Quick facts

Lead sponsor	Gang Wang, MD
Status	Status unknown
Study type	OBSERVATIONAL
Enrollment	2,500
Start date	15 March 2023
Primary completion	30 May 2023
Estimated completion	30 July 2023
Sites	12 locations across China

Conditions studied

Psoriasis Patients — all drugs for Psoriasis Patients →
COVID-19 — all drugs for COVID-19 →

Sponsor

Gang Wang, MD

Who can join

Eligibility, any sex, with Psoriasis Patients or COVID-19. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

A retrospective analysis based on database was conducted to evaluate the correlation between covid-19 infection and the condition and treatment of psoriasis patients.

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

Clinical characteristics and outcomes of psoriasis patients with COVID-19: A retrospective, multicenter cohort study in China.
Liu Y, Xu Z, Zhou J, Chen A, et al · · 2024 · PMID 38710539 · DOI 10.1097/cm9.0000000000003024
Clinical characteristics and outcomes of psoriasis patients with COVID-19: a retrospective, multicenter cohort study in China
Liu Y, Xu Z, Wang G, Yu C, et al · · 2023 · DOI 10.21203/rs.3.rs-3352492/v1

Verify or expand the search:

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05961605 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Gang Wang, MD
Last refreshed: 1 August 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05961605.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing